The India pathology lab services market size reached USD 17.76 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 43.55 Billion by 2033, exhibiting a growth rate (CAGR) of 9.67% during 2025-2033. The rising healthcare awareness, growing prevalence of chronic diseases, increasing demand for preventive diagnostics, expanding health insurance coverage, government health initiatives, rising disposable incomes, improved access to diagnostic centers, growing medical tourism, continual technological advancements in diagnostic tools, and increasing investments in healthcare infrastructure are some of the major factors expanding the India pathology lab services market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 17.76 Billion |
Market Forecast in 2033 | USD 43.55 Billion |
Market Growth Rate 2025-2033 | 9.67% |
Growth in Home Sample Collection and Digital Integration
The demand for home sample collection is increasing, accelerated by the COVID-19 pandemic, and now embedded as a consumer expectation. Additionally, urban consumers, especially working professionals and the elderly, prefer the convenience of at-home testing. Therefore, labs are expanding phlebotomist networks and investing in home sample collection, mobile apps, call centers, and digital platforms that allow for test booking, sample tracking, and online report delivery. For instance, on January 17, 2025, Curelo, a rapidly growing healthcare platform in India, launched CURELO FLASH, a pioneering 10-minute doorstep blood sample collection service, following a successful pilot in Gurugram. This kind of rapid, tech-enabled service sets a new benchmark for responsiveness in diagnostics and reflects growing competition among pathology providers to offer faster, more user-friendly experiences. Furthermore, integration with wearable health data and teleconsultation platforms is beginning to take shape, thereby offering a more connected diagnostic experience. Labs are also developing loyalty programs, test packages, and subscription models through these apps to retain users, which is contributing to the India pathology lab services market growth. Data privacy and cybersecurity have become critical focus areas, given the volume of personal health data being collected and shared. This digital layer is not just about convenience, as it is reshaping customer engagement, backend operations, and how labs differentiate themselves in a crowded market.
Rising Burden of Chronic Diseases Driving Preventive Diagnostics
India is facing a steady increase in lifestyle-related chronic diseases such as diabetes, hypertension, cardiovascular conditions, obesity, and certain types of cancer. These ailments are no longer limited to older population as the younger demographic is also being affected due to sedentary lifestyles, poor diet, stress, and lack of physical activity. According to a survey, 52% of Indian women and 48% of Indian males are at risk of developing health issues related to lifestyle choices. And, a growing number of people are suffering from conditions including diabetes, thyroid problems, lipid imbalances, kidney problems, fatty liver disease, arthritis, cardiovascular illnesses, and cancer. According to industry reports, non-communicable illnesses and injuries are responsible for 52% of fatalities in India. This is shifting consumer behavior toward preventive healthcare, with a sharp rise in demand for early detection and regular health monitoring, which is positively impacting pathology lab services market outlook. In addition to this, pathology labs are capitalizing on this by offering bundled preventive packages that include blood glucose, lipid profiles, liver, and kidney function tests, thyroid panels, and vitamin assessments. Besides this, preventive diagnostics offer a recurring business for labs and encourage higher consumer engagement throughout the year, not just during illness. The focus is further extending to disease risk assessments, enabling people to monitor hereditary and lifestyle-related risks before symptoms appear. This shift is pushing pathology players to develop more comprehensive, yet affordable diagnostic packages suited for periodic screening.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on type, testing services, and end use.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes hospital-based, standalone labs, and diagnostic chains.
Testing Services Insights:
A detailed breakup and analysis of the market based on the testing services have also been provided in the report. This includes general physiological and clinical tests, imaging and radiology tests, esoteric tests, and COVID-19 tests.
End Use Insights:
The report has provided a detailed breakup and analysis of the market based on the end use. This includes physician referrals, walk-ins, and corporate.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Hospital-based, Standalone Labs, Diagnostic Chains |
Testing Services Covered | General Physiological and Clinical Tests, Imaging and Radiology Tests, Esoteric Tests, COVID-19 Tests |
End Uses Covered | Physician Referrals, Walk-ins, Corporate |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |